The company determined freedom to operate and commercial viability. A new patent application has been filed. The market potential for BioSeedMat / Gel was clearly demonstrated in the organic market as anticipated, but the study identified a larger market with conventional growers driven by the review and withdrawal of pesticides under EU Legislation. Market analysis showed market to be 584,000 ha of close-spaced crops in the EU where BioSeedMat / Gel has the most commercial potential. The Company concluded that the best route to market is through a licensing model for users and distributors for both geographic territories and product sectors. It believes it can sell sufficient licences to generate substantial profit from Royalty fees and in-house activity, to give a return of 339% on investment within 5 years. We believe there is a compelling case for developing BioSeedMat / Gel as the primary agent for replacing pesticides for weed control in the global agriculture market. A commercial project, funded by the SME Instrument Phase 2, will generate substantial growth in employment and profits for the company and its partners in the EU and wider international markets.